- Report
- August 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- March 2026
- 138 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- July 2026
- 218 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- June 2026
- 200 Pages
Global
From €2749EUR$2,990USD£2,337GBP
- Report
- April 2026
- 200 Pages
Global
From €2749EUR$2,990USD£2,337GBP
- Report
- May 2026
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- May 2026
- 150 Pages
Global
From €5469EUR$5,950USD£4,650GBP
- Report
- April 2026
- 200 Pages
Global
From €2749EUR$2,990USD£2,337GBP
- Report
- February 2026
Global
From €4504EUR$4,900USD£3,830GBP
- Report
- January 2026
- 188 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 180 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 191 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 186 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 190 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 190 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 187 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 183 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more